Updated:
Eir Pharmaceuticals
Eir Pharmaceuticals, a Palo Alto-headquartered pharmaceutical entity, maintains offices across six US cities.
Eir Pharmaceuticals
EIR Pharmaceuticals is a pharmaceutical company founded in 2018 and headquartered in Olathe, Kansas.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Palo Alto
Corporate office
Palo Alto, CA, United States
Additional offices
Los Angeles, CA, United States · New York, NY, United States · Olathe, KS, United States · Santa Monica, CA, United States · Dallas, TX, United States
Frequently asked questions
Does Eir Pharmaceuticals operate as a family office or an investment manager?
There is no public evidence that Eir Pharmaceuticals is structured as a family office or investment manager. It appears in corporate records as a pharmaceuticals operating company. No SEC-registered investment advisor filing, Form ADV, or state-level investment registration is associated with the name. Without a website or disclosed principals, there is no basis to classify it as anything other than an operating entity.
What is the firm's investment strategy or asset-class focus?
No investment strategy or asset-class focus has been publicly disclosed. The entity's name indicates pharmaceuticals, which is an operating business sector rather than an investment mandate. Allocators seeking a pharma-focused investment vehicle would need to confirm directly with the firm whether it deploys capital into financial assets.
Who runs Eir Pharmaceuticals?
No principals, executives, or board members are identified in any publicly available source for Eir Pharmaceuticals. Standard searches across corporate filings, press releases, and professional networks do not surface a named founder, CEO, or managing partner for this entity.
Where is Eir Pharmaceuticals headquartered, and where does it operate?
The entity lists a Palo Alto, California headquarters with additional offices in Los Angeles, New York, Olathe (Kansas), Santa Monica, and Dallas. This six-market footprint is unusual for a firm with no digital presence or disclosed operational activity.
Has Eir Pharmaceuticals raised any disclosed funding or registered any securities?
No disclosed funding rounds, securities registrations, or Form D filings have been found for Eir Pharmaceuticals in standard databases, including SEC EDGAR. The firm appears to operate without any public capital-raising history.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: